MedImmune, Inc. v. Genentech, Inc.

MedImmune, Inc. v. Genentech, Inc.
MedImmune, Inc. v. Genentech, Inc.
Seal of the United States Supreme Court.svg
Supreme Court of the United States
Argued October 4, 2006
Decided January 9, 2007
Full case name MedImmune, Inc. v. Genentech, Inc.
Docket nos. 05-608
Holding
Contrary to respondents’ assertion that only a freestanding patent-invalidity claim is at issue, the record establishes that petitioner has raised and preserved the contract claim that, because of patent invalidity, unenforceability, and noninfringement, no royalties are owing. 427 F. 3d 958, reversed and remanded.
Court membership
Case opinions
Majority Scalia, joined by Roberts, Stevens, Kennedy, Souter, Ginsburg, Breyer, Alito
Dissent Thomas

MedImmune, Inc. v. Genentech, Inc., 549 U.S. 118 (2007) was a decision by the Supreme Court of the United States involving patent law. It arose from a lawsuit filed by MedImmune which challenged one of the Cabilly patents issued to Genentech. One of the central issues was whether a licensee retained the right to challenge a licensed patent, or whether this right was forfeited upon signing of the license agreement. The case related indirectly to current debate over whether the US should change to a first to file patent system.

The origin of the dispute was a lengthy interference proceeding between Genentech and Celltech which led to the issuance of a new patent in 2001, 18 years after the original filing. This effectively granted Genentech a patent term of 29 years. MedImmune was a licensee of the later Cabilly patent, but argued that the term had been improperly extended and that it need not continue to pay royalties past the original expiry date in March 2006. The case was decided in favor of MedImmune, and the United States Patent and Trademark Office (USPTO) declared the patent invalid. Genentech appealed to the USPTO the ruling and the patent remained valid and enforceable until the appeal was concluded. Genentech prevailed during the reexamination of Cabilly II(2) by the USPTO (1). GlaxoSmithKline and Human Genome Sciences both are challenging the patent under antitrust law (1). This is based on the settlement between Genentech and Celltech and their dispute over the original Cabilly patent 4,816,567 and the Celltech's patent 4,816,397. Both of which issued on March 28, 1989 (2),(3). Cabilly II is patent 6331415(4) which issued December 18, 2001.

See also

1)http://www.biolawgics.com/patent-law/the-never-ending-battle-over-genentechs-cabilly-ii-patent/

2)http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=4816397.PN.&OS=PN/4816397&RS=PN/4816397

3)http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=4816567.PN.&OS=PN/4816567&RS=PN/4816567

4) http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=6331415.PN.&OS=PN/6331415&RS=PN/6331415

Further reading

External links


Wikimedia Foundation. 2010.

Игры ⚽ Поможем написать курсовую

Look at other dictionaries:

  • MedImmune — MedImmune, LLC Type Subsidiary of AstraZeneca Industry Pharmaceutical Headquarters Gaithersburg, Ma …   Wikipedia

  • Cabilly patents — The Cabilly patents are two US patents issued to Genentech which relate to the fundamental technology required for the artificial synthesis of antibody molecules . Fact|date=September 2007 The name refers to the lead inventor Shmuel Cabilly.… …   Wikipedia

  • Declaratory judgment — A declaratory judgment is a judgment of a court in a civil case which declares the rights, duties, or obligations of one or more parties in a dispute. A declaratory judgment is legally binding, but it does not order any action by a party.[1] In… …   Wikipedia

  • Declaratory ruling — A declaratory judgment is a judgment of a court in a civil case which declares the rights, duties, or obligations of each party in a dispute. It is commonly called a declaratory ruling, a term which also includes decisions of regulatory agencies …   Wikipedia

  • Biotech — Als Biotechnologie wird die Umsetzung von Erkenntnissen aus der Biologie und der Biochemie in technische oder technisch nutzbare Elemente verstanden. Die Kurzform Biotech wird meist auf kommerzielle Betriebe angewandt, die in diesem Bereich… …   Deutsch Wikipedia

  • Biotechnik — Als Biotechnologie wird die Umsetzung von Erkenntnissen aus der Biologie und der Biochemie in technische oder technisch nutzbare Elemente verstanden. Die Kurzform Biotech wird meist auf kommerzielle Betriebe angewandt, die in diesem Bereich… …   Deutsch Wikipedia

  • List of United States patent law cases — This is a list of patent law cases in the United States from 1878 to 2007.Early cases*City of Elizabeth v. American Nicholson Pavement Co. 1878. Prior use does not include experimental use. *Egbert v. Lippmann 1881. Held that public use of an… …   Wikipedia

  • 2006 term opinions of the Supreme Court of the United States — This is a list of the opinions delivered from the bench by the Supreme Court of the United States during its 2006 term, which began on October 2, 2006, and concluded September 30, 2007, and statistics associated therewith. The table illustrates… …   Wikipedia

  • List of United States Supreme Court cases, volume 549 — This is a list of all the United States Supreme Court cases from volume 549 of the United States Reports :* Ayers v. Belmontes ussc|549|7|2006 * BP America Production Co. v. Burton ussc|549|84|2006 * Burton v. Stewart ussc|549|147|2007 * Carey v …   Wikipedia

  • Altvater v. Freeman — Infobox SCOTUS case Litigants = Altvater v. Freeman ArgueDate = April 19 ArgueYear = 1943 DecideDate = May 24 DecideYear = 1943 FullName = Altvater v. Freeman USVol = 319 USPage = 359 Citation = 319 U.S. 359 Prior = Subsequent = Holding =… …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”